Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Extensive Stage Lung Small Cell Carcinoma × LB100 × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Extensive Stage Lung Small Cell Carcinoma 1

Interventions

atezolizumab 3 Etoposide 2 Carboplatin 2 lipoarabinomannan 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Magnetic Resonance Spectroscopy 1 Lamivudine 1 LB100 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04560972 2025-11-10

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

City of Hope Medical Center

Phase 1 Active not recruiting

Extensive Stage Lung Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡